CNO Financial Group (CNO) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Achieved record new annualized premiums of $120 million, up 17% year-over-year, with double-digit insurance sales growth and multiple product line sales records; 12th consecutive quarter of strong sales momentum.
Operating earnings per diluted share were $0.87, with operating ROE (excluding significant items) at 11.2% for 2Q25; book value per diluted share (ex-AOCI) rose 6% to $38.05.
Net income for Q2 2025 was $91.8 million, down from $116.3 million in Q2 2024, with both periods affected by non-economic accounting impacts from market volatility.
Returned $117 million to shareholders in the quarter and $234 million year to date; share repurchases reduced weighted average diluted shares outstanding by 8% over the trailing 12 months.
Business fundamentals remain strong, with consistent execution of the strategic plan and sustained sales momentum.
Financial highlights
Total revenues for Q2 2025 were $1.15 billion, up from $1.07 billion in Q2 2024; net investment income for Q2 2025 was $483.7 million, up from $409.1 million in Q2 2024.
Net operating income for Q2 2025 was $87.5 million, compared to $114.6 million in Q2 2024; insurance product margin for Q2 2025 was $252.4 million, down from $275.1 million in Q2 2024.
Book value per diluted share (ex-AOCI) at $38.05, up 6% year-over-year; book value per common share as of June 30, 2025 was $25.92.
Debt to capital ratio improved to 26.1% at June 30, 2025, down from 32.1% at year-end 2024.
Operating return on equity was 11.8% (trailing 12 months) and 11.2% excluding significant items.
Outlook and guidance
Reaffirmed 2025 guidance, targeting $3.70–$3.90 operating EPS and a narrowed expense ratio range of 19.0%–19.2% due to better operating leverage.
On track to achieve a 10.5% operating ROE for 2025 and a three-year target of 11.5% by 2027, with a 150 basis point improvement in run rate operating ROE by 2027.
Expecting $200–$250 million excess cash flow to holding company and maintaining a 375% consolidated RBC ratio.
Effective tax rate expected to remain around 23% for 2025.
Guidance does not reflect any new treaties with the Bermuda company; ongoing discussions with regulators continue.
Latest events from CNO Financial Group
- Record premiums, 11% EPS growth, and strong capital returns highlight robust 2025 results.CNO
Q4 20256 Feb 2026 - Operating EPS up 94%, guidance raised, and strong growth in sales and agent productivity.CNO
Q2 20242 Feb 2026 - Growth momentum driven by middle market focus, agent productivity, and operational efficiency.CNO
2024 KBW Insurance Conference22 Jan 2026 - Operating earnings and annuity sales surged, prompting raised 2024 guidance and strong capital returns.CNO
Q3 202417 Jan 2026 - Operating EPS up 52%, guidance reaffirmed, and capital strength and buybacks continued.CNO
Q1 202524 Dec 2025 - Record earnings, sales, and capital returns in 2024, with strong ROE and growth outlook.CNO
Q4 202422 Dec 2025 - Record financial performance, robust governance, and key plan amendments drive 2025 proxy agenda.CNO
Proxy Filing1 Dec 2025 - Record financial results, increased shareholder returns, and key governance votes mark 2025's agenda.CNO
Proxy Filing1 Dec 2025 - Director elections, compensation, auditor ratification, and ESG initiatives headline the agenda.CNO
Proxy Filing1 Dec 2025